Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Generic Dioralyte oral powder sachets
0902012H0AAAEAE
|
Oral rehydration salts | Oral rehydration salts | Nutrition and Blood | 29 |
|
Glytactin Build 20/20 oral powder 30g sachets neutral
0913205E0BCABAC
|
Glytactin powder 20g GMP protein equivalent | Powder 20g GMP protein equivalent (0913205) | Nutrition and Blood | 29 |
|
MSUD explore5 oral powder 12.5g sachets
0913225A0BBAAAA
|
MSUD powder 5g protein equivalent (0913225) | Powder 5g protein equivalent (0913225) | Nutrition and Blood | 29 |
|
Phytomenadione 200micrograms/ml oral drops sugar free
0906060Q0AAAZAZ
|
Phytomenadione | Phytomenadione | Nutrition and Blood | 29 |
|
PKU Air20 yellow liquid
0913205N0BBAGAE
|
PKU ready to serve 20g protein equivalent | Ready to serve 20g protein equivalent (0913205) | Nutrition and Blood | 29 |
|
Pro D3 3,200unit Vegan capsules
0906040G0BIALDF
|
Pro D3 | Colecalciferol | Nutrition and Blood | 29 |
|
ThiamEss 50mg tablets
0906026M0BIABAF
|
Thiamess | Thiamine hydrochloride | Nutrition and Blood | 29 |
|
Vivomixx capsules
0913531B0BBAAAA
|
Vivomixx capsules delisted probiotic | Capsules delisted probiotic (0913531) | Nutrition and Blood | 29 |
|
Aranesp 10micrograms/0.4ml inj pre-filled syringes
0901030J0BBAHAH
|
Aranesp | Darbepoetin alfa | Nutrition and Blood | 28 |
|
Calcium carbonate 1.25g tablets
0905011D0AAAEAE
|
Calcium carbonate (Supplements) | Calcium carbonate | Nutrition and Blood | 28 |
|
Ergocalciferol 10,000units/5ml oral solution
0906040N0AAFIFI
|
Ergocalciferol | Ergocalciferol | Nutrition and Blood | 28 |
|
Ergoral D2 10,000unit tablets
0906040N0BYACAM
|
Ergoral D2 | Ergocalciferol | Nutrition and Blood | 28 |
|
Essential Amino Acid Mix powder
0913445B0BDAAAC
|
Essential Amino Acid pdr disc/non ACBS protein SfI meta cond | Pdr disc/non ACBS protein SfI metabolic condition (0913445) | Nutrition and Blood | 28 |
|
FlavourPac oral powder 4g sachets tropical
0913302A0BBADAA
|
FlavourPac powder flavour additive | Powder flavour additive (0913302) | Nutrition and Blood | 28 |
|
Fluoritop HF 5000ppm fluoride toothpaste
0905030G0BQAABY
|
Fluoritop | Sodium fluoride | Nutrition and Blood | 28 |
|
Levocarnitine 1g/10ml soln unit dose vials sugar free
0908010C0AAAAAA
|
Levocarnitine | Levocarnitine | Nutrition and Blood | 28 |
|
MSUD gel 24g sachets
0913225C0BBABAB
|
MSUD ready to serve 10g protein equivalent (0913225) | Ready to serve 10g protein equivalent (0913225) | Nutrition and Blood | 28 |
|
Paricalcitol 2microgram capsules
0906040P0AAADAD
|
Paricalcitol | Paricalcitol | Nutrition and Blood | 28 |
|
PKU Maxamum powder unflavoured
0913205G0BBABAA
|
PKU powder 39g protein equivalent per 100g | Powder 39g protein equivalent per 100g (0913205) | Nutrition and Blood | 28 |
|
Potassium chloride 375mg/5ml oral solution
0902011U0AAARAR
|
Potassium chloride (Systemic) | Potassium chloride | Nutrition and Blood | 28 |
|
Pro-Cal powder starter pack
0913141F0BBACAA
|
Pro-Cal powder 6.7 kcal/g energy and protein fortifier | Powder 6.7 kcal/g energy and protein fortifier (0913141) | Nutrition and Blood | 28 |
|
PyridoxEss 50mg tablets
0906024N0CMACAI
|
PyridoxEss | Pyridoxine hydrochloride | Nutrition and Blood | 28 |
|
Water for injections 100ml bottles
0902021X0AABBBB
|
Water for injection | Water for injection | Nutrition and Blood | 28 |
|
XPhe jump 10 liquid (6 flavours)
0913205K0BDAAAB
|
Xphe ready to serve 10g protein equivalent | Ready to serve 10g protein equivalent (0913205) | Nutrition and Blood | 28 |
|
Aymes ActaSolve Protein Compact Starter Pack powder
0913011H0BBAAAA
|
Aymes powder 2.4 kcal/ml m/sk lower volume, higher prot | Pdr 2.4 kcal/ml m/sk lower volume, higher protein (0913011) | Nutrition and Blood | 27 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.